Period Ending | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 | Mar 30, 2012 |
---|
Total Revenue
|
1,900,192
|
1,967,171
|
1,862,747
|
2,046,744
| Cost of Revenue | 894,063 | 966,344 | 892,029 | 996,550 | |
Gross Profit
|
1,006,129
|
1,000,827
|
970,718
|
1,050,194
| |
|
Operating Expenses |
|
Research Development | 118,162 | 127,787 | 111,504 | 120,237 |
|
Selling General and Administrative | 495,878 | 484,260 | 455,116 | 501,707 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
392,089
|
388,780
|
404,098
|
428,250
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 8,636 | 8,410 | 4,373 | 21,335 |
|
Earnings Before Interest And Taxes | 400,725 | 397,190 | 408,471 | 449,585 |
|
Interest Expense | 35,029 | 35,291 | 34,849 | 35,140 |
|
Income Before Tax | 365,696 | 361,899 | 373,622 | 414,445 |
|
Income Tax Expense | 95,447 | 87,620 | 91,932 | 109,430 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 270,249 | 274,279 | 281,690 | 305,015 | |
|
Non-recurring Events |
|
Discontinued Operations | 355,187 | 14,764 | 45,175 | (13,981) |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
625,436
|
289,043
|
326,865
|
291,034
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
625,436
|
289,043
|
326,865
|
291,034
|
|